Genkyotex is a startup based in Switzerland, most recent round Acquired, 3 tracked investors.
Genkyotex is a company founded in 2003 headquartered in Switzerland. Genkyotex has been acquired. Brouky records 3 investors associated with the company.
Genkyotex was a clinical-stage biotechnology company focused on developing novel NOX inhibitors for the treatment of severe diseases, particularly fibrotic and inflammatory conditions. The company was acquired by Calliditas Therapeutics in 2020.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.